| Targeting PIM kinase enhances the activity of sunitinib in renal cell ... - UroToday |
|
|
UroToday We hypothesised that inhibition of PIM kinase activity with SGI-1776, a novel small molecule inhibitor of PIM kinase activity, would reduce the viability of renal cell carcinoma (RCC) cells and enhance the activity of sunitinib. Immunoblotting, qRT-PCR |